R C M Technologies Inc <RCMT.O>: Benchmark raises target price to $45 from $36
RCMT•Related News
Bread Financial July net principal loss rate falls to 6.8% from 7.63%
BFH•
Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
FTH•
Freightos Q2 revenue hits record, loss narrows as Mideast activity resumes
CRGO•
Castle Biosciences begins dual listing on Nasdaq Texas under CSTL
CSTL•
Reddit <RDDT.N>: Raymond James raises target price to $205 from $200
RDDT•